RT @Osteoporosis_NL: Bisphosphonate use was associated with lower mortality within days of treatment initiation; consistent with confoundin…
RT @Osteoporosis_NL: Bisphosphonate use was associated with lower mortality within days of treatment initiation; consistent with confoundin…
Good news.
#Bisphosphonates and #mortality : confounding in observational studies? Nice work from the Nordstrom’s in #Sweden . Notice most mortality benefit relates to reduction in #cardiovascular diseases https://t.co/1RqSIjorhe
RT @Osteoporosis_NL: Bisphosphonate use was associated with lower mortality within days of treatment initiation; consistent with confoundin…
RT @Osteoporosis_NL: Bisphosphonate use was associated with lower mortality within days of treatment initiation; consistent with confoundin…
RT @Osteoporosis_NL: Bisphosphonate use was associated with lower mortality within days of treatment initiation; consistent with confoundin…
The #mortalityrate in #bisphosphonate users was a 15% lower (HR 0.85, 95% CI 0.79-0.91). The #risk of #death was lower in #bisphosphonateusers from #day6 of #treatment in #osteoporosis. The association was not significant until the #secondweek. https:/
RT @Osteoporosis_NL: Bisphosphonate use was associated with lower mortality within days of treatment initiation; consistent with confoundin…
RT @Osteoporosis_NL: Bisphosphonate use was associated with lower mortality within days of treatment initiation; consistent with confoundin…
Bisphosphonate use was associated with lower mortality within days of treatment initiation; consistent with confounding, although an early treatment effect cannot be ruled out. Bergma J et al. Osteoporos Int (31 JULY 2019). https://t.co/oKbbyAnwX1 https:/